Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: In vivo and ex vivo evidence from ecSOD-deficient mice

Circulation Research

Volumn 93, Issue 7, 2003, Pages 622-629

  Jung, Oliver ^a   Marklund, Stefan L ^b   Geiger, Helmut ^a   Pedrazzini, Thierry ^c   Busse, Rudi ^a   Brandes, Ralf P ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c University of Lausanne Medical Center   (Switzerland)

Author keywords

Angiotensin; Endothelium; Hypertension; Oxidative stress; Superoxide dismutase

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; LUCIGENIN; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TIRON; ANGIOTENSIN II; CATALASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RECOMBINANT PROTEIN; SUPEROXIDE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE REGULATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME MECHANISM; EXTRACELLULAR SPACE; HYPERTENSION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL ARTERY; RENOVASCULAR HYPERTENSION; VASODILATATION; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITROPRUSSIDE; PHENYLEPHRINE; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0141864392     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000092140.81594.A8     Document Type: Article

References (31)

1. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
2. McCord JM, Fridovich I. Superoxide dismutase. J Biol Chem. 1969;244:6049-6055.
3. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A. 1982;79:7634-7638.
4. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res. 2002;55:239-249.
5. Mügge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol. 1991;260:C219-C225.
6. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res. 2002;91:938-944.
7. Marklund SL. Extracellular superoxide dismutase. Methods Enzymol. 2002;349:74-80.
8. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension. 1997;29:1025-1030.
9. Tibell L, Hjalmarsson K, Edlund T, Skogman G, Engstrom A, Marklund SL. Expression of human extracellular superoxide dismutase in Chinese hamster ovary cells and characterization of the product. Proc Natl Acad Sci USA. 1987;84:6634-6638.
10. Brandes RP, Miller FJ, Beer S, Haendeler J, Hoffmann J, Ha T, Holland SM, Gorlach A, Busse R. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med. 2002;32:1116-1122.
11. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26-32.
12. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest. 1996;75:617-636.
13. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
14. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A. 1995;92:6264-6268.
15. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest. 1999;103:1055-1066.
16. Demchenko IT, Oury TD, Crapo JD, Piantadosi CA. Regulation of the brain's vascular responses to oxygen. Circ Res. 2002;91:1031-1037.
17. Topouzis S, Schott C, Stoclet JC. Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by α-adrenoceptor agonists in rat aorta. J Cardiovasc Pharmacol. 1991;18:670-678.
18. Dowell FJ, Martin W, Dominiczak AF, Hamilton CA. Decreased basal despite enhanced agonist-stimulated effects of nitric oxide in 12-week-old stroke-prone spontaneously hypertensive rat. Eur J Pharmacol. 1999;379:175-182.
19. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, Macharzina R, Brasen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999;55:252-260.
20. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 1996;97:1916-1923.
21. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
22. phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.
23. Fukui T, Ishizaka N, Rajapopalan S, Laursen JB, Capers Q, Taylor WR, Harrison DG, deLeon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
24. Fennell JP, Brosnan MJ, Frater AJ, Hamilton CA, Alexander MY, Nicklin SA, Heistad DD, Baker AH, Dominiczak AF. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther. 2002;9:110-117.
25. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res. 2003;92:461-468.
26. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J. 1984;222:649-655.
27. - and systolic blood pressure in mice. Circ Res. 2001;89:408-414.
28. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947-953.
29. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res. 1999;85:23-28.
30. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000;105:1631-1639.
31. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation. 2000;101:2264-2270.